Axial spondyloarthritis — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Objective inflammation permits escalation despite absent radiographic sacroiliitis
The treatment pathway includes non-radiographic axial spondyloarthritis when a rheumatologist verifies active disease and objective inflammation through raised CRP or MRI. Persistent high activity despite appropriate non-pharmacological care and NSAIDs can therefore justify targeted-therapy assessment without waiting for radiographic damage.
Reference: NICE NG65: spondyloarthritis in over 16s — recommendations (Updated June 2017): https://www.nice.org.uk/guidance/ng65/chapter/Recommendations; 2025 BSR guideline for axial spondyloarthritis with biologic and targeted synthetic DMARDs (Published April 2025): https://academic.oup.com/rheumatology/article/64/6/3242/8108015